Nosology

Meridian Bioscience to Hold Third Quarter Fiscal 2021 Financial Results Conference Call on August 6, 2021

Retrieved on: 
Wednesday, July 14, 2021
Medical diagnosis, Medical terminology, Nosology, NASDAQ, Finance, New York City, Financial markets

CINCINNATI, July 14, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, will report third quarter fiscal 2021 financial results Friday, August 6, 2021.

Key Points: 
  • CINCINNATI, July 14, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, will report third quarter fiscal 2021 financial results Friday, August 6, 2021.
  • Jack Kenny, Chief Executive Officer, and Bryan Baldasare, Executive Vice President and Chief Financial Officer, will host a conference call beginning at 10:00 a.m. Eastern Time to discuss the results and answer questions.
  • Meridian is a fully integrated life science company that develops, manufactures, markets and distributes a broad range of innovative diagnostic products.
  • Through diagnosis, we provide diagnostic solutions in areas including gastrointestinal and upper respiratory infections and blood lead level testing.

SurveyVitals Unveils New Question Bank Feature

Retrieved on: 
Friday, July 9, 2021
Medical diagnosis, Medical terminology, Nosology, Health care

BOISE,Idaho, July 9, 2021 /PRNewswire/ -- SurveyVitals, Inc., a patient experience analytics platform, today announced the release of its groundbreaking, enhanced patient experience survey tool, Question Bank.

Key Points: 
  • BOISE,Idaho, July 9, 2021 /PRNewswire/ -- SurveyVitals, Inc., a patient experience analytics platform, today announced the release of its groundbreaking, enhanced patient experience survey tool, Question Bank.
  • Designed to help healthcare organizations identify and act on improvement opportunities like never before, Question Bank equips users with the ability to create and deliver custom questions to target audiences in real-time.
  • "Healthcare leaders are increasingly looking for dynamic solutions to support a more meaningful understanding of a patient's journey," said Blake Vosburgh, President of SurveyVitals.
  • "The focused level of insight provided by Question Bank not only allows for rapid diagnosis of specific improvement opportunities, but the ability to modulate campaigns and behavior in near real-time.

Natus Medical to Hold 2021 Second Quarter Financial Results Conference Call on August 6th

Retrieved on: 
Thursday, July 1, 2021
Medical diagnosis, Medical terminology, Nosology, Medicine

PLEASANTON, Calif., July 01, 2021 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: NTUS), (the Company or Natus), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages, announced today that the Company will release its 2021 second quarter financial results after the close of the market on Thursday, August 5th.

Key Points: 
  • PLEASANTON, Calif., July 01, 2021 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: NTUS), (the Company or Natus), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages, announced today that the Company will release its 2021 second quarter financial results after the close of the market on Thursday, August 5th.
  • Natus management will host a conference call on Friday, August 6th at 8:00 a.m. Eastern Time (5:00 a.m. Pacific Time) to discuss those results and to answer questions.
  • Individuals interested in listening to the conference call may do so by dialing 1-844-634-1441 for domestic callers, or 1-508-637-5658 for international callers, and entering reservation code 1379298.
  • Natus is a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages.

2021-2022 Fellows in Diagnostic Excellence Announced - SIDM Welcomes Eight New Fellows to Focus on Diagnostic Quality and Safety Projects

Retrieved on: 
Friday, June 25, 2021
Medical diagnosis, Medical terminology, Nosology

EVANSTON, Ill., June 25, 2021 /PRNewswire-PRWeb/ --Eight new Fellows in Diagnostic Excellence were announced today by the Society to Improve Diagnosis in Medicine (SIDM).

Key Points: 
  • EVANSTON, Ill., June 25, 2021 /PRNewswire-PRWeb/ --Eight new Fellows in Diagnostic Excellence were announced today by the Society to Improve Diagnosis in Medicine (SIDM).
  • The 2021-2022 Fellowship in Diagnostic Excellence awardees will work on innovative projects focused on improving diagnostic quality and safety.
  • "Our Fellowship in Diagnostic Excellence program continues to attract exceptional candidates who are poised to advance the field of diagnostic quality and safety," said Paul Bergl, MD, fellowship director and 2017 Fellow.
  • Together, we work to find solutions that enhance diagnostic safety and quality, reduce harm, and ultimately, ensure better health outcomes for patients.

GekkoVet Oy: Has My Dog Got Corona Virus Disease, Cholangitis or Kennel Cough?

Retrieved on: 
Thursday, June 17, 2021
Professional services, Health, Consumer, Insurance, Pets, Veterinary, Medical terminology, Medicine, Branches of biology, Medical diagnosis, Nosology, Veterinarian, Psychiatric diagnosis, Health care

In treating their patients, veterinarians use numerous different sources to arrive at a diagnosis.

Key Points: 
  • In treating their patients, veterinarians use numerous different sources to arrive at a diagnosis.
  • Now, however, there is no longer a need for stacks of books or confusing notes.
  • GekkoCompass creates a list of possible diagnoses in probability order, based on the patients symptoms, laboratory results, and other findings.
  • Johanna Majamaa, CEO of GekkoVet Oy, states: The main idea behind this applications development has been the desire to promote animal welfare worldwide.

Veracyte to Present at Upcoming Investor Conferences

Retrieved on: 
Wednesday, May 26, 2021
Oncology, Health, Genetics, Research, Pharmaceutical, Science, Medical diagnosis, Medical terminology, Nosology, Medicine, Branches of biology

Replays of the webcasts will be available for 90 days following the conclusion of each live presentation broadcast.

Key Points: 
  • Replays of the webcasts will be available for 90 days following the conclusion of each live presentation broadcast.
  • Veracyte (Nasdaq: VCYT) is a global genomic diagnostics company that improves patient care by providing answers to clinical questions, informing diagnosis and treatment decisions throughout the patient journey in cancer and other diseases.
  • With Veracytes exclusive global license to a best-in-class diagnostics instrument platform, the company is positioned to deliver its tests to patients worldwide.
  • For more information, please visit www.veracyte.com and follow the company on Twitter (@veracyte).

CENTOGENE Discovers Six New Rare Diseases by Leveraging the Strength of Its Bio/Databank

Retrieved on: 
Wednesday, May 5, 2021
Medicine, Branches of biology, Clinical medicine, Medical genetics, Medical diagnosis, Medical terminology, Nosology, Rare disease, Genetic testing, Diagnosis

The findings are a result of in-depth analyses into the Company\xe2\x80\x99s rare disease Bio/Databank, after standard genetic testing was unable to determine the exact cause of symptoms.

Key Points: 
  • The findings are a result of in-depth analyses into the Company\xe2\x80\x99s rare disease Bio/Databank, after standard genetic testing was unable to determine the exact cause of symptoms.
  • As a result, over 90 patients were able to finally receive a diagnosis \xe2\x80\x93 opening the potential to diagnose countless others following further research.
  • Peter Bauer, Chief Genomic Officer at CENTOGENE, said, \xe2\x80\x9cThere are more than 7,000 rare diseases that are known to date, and our research shows that there are even more to be identified.
  • In this case, we were able to provide patients with a diagnosis with diseases that were not previously on anyone\xe2\x80\x99s radar.

AllStripes Announces Collaboration with NIH’s NCATS to Launch Effort in Rare Disease Diagnosis

Retrieved on: 
Tuesday, April 27, 2021
Health, Other Health, Clinical trials, General Health, Pharmaceutical, Biotechnology, Medical diagnosis, Medical terminology, Nosology, Rare disease

NCATS and AllStripes share a like-minded vision of the urgency to change this paradigm and help bring forward new treatments and diagnostic approaches, faster,\xe2\x80\x9d said Nancy Yu, co-founder and chief executive officer of AllStripes.

Key Points: 
  • NCATS and AllStripes share a like-minded vision of the urgency to change this paradigm and help bring forward new treatments and diagnostic approaches, faster,\xe2\x80\x9d said Nancy Yu, co-founder and chief executive officer of AllStripes.
  • \xe2\x80\x9cBy leveraging our technology platform, AllStripes and NCATS will collaborate on two studies aimed at identifying opportunities to speed diagnosis and raising awareness of the economic and human cost of rare disease among key stakeholders.
  • A second study will capture data on the diagnostic journey in two rare diseases, with the goal of identifying algorithms and opportunities to speed diagnosis.
  • AllStripes was founded by CEO Nancy Yu and technology developer Onno Faber, following his diagnosis and journey with the rare disease neurofibromatosis type 2.

Meridian Bioscience to Hold Second Quarter Fiscal 2021 Financial Results Conference Call on May 7, 2021

Retrieved on: 
Monday, April 19, 2021
Medical diagnosis, Medical terminology, Nosology

We are dedicated to developing and delivering better solutions that give answers with speed, accuracy and simplicity that are redefining the possibilities of life from discovery to diagnosis.

Key Points: 
  • We are dedicated to developing and delivering better solutions that give answers with speed, accuracy and simplicity that are redefining the possibilities of life from discovery to diagnosis.
  • Through discovery and development, we provide critical life science raw materials used in immunological and molecular tests for human, animal, plant, and environmental applications.
  • Through diagnosis, we provide diagnostic solutions in areas including gastrointestinal and upper respiratory infections and blood lead level testing.
  • Meridian\xe2\x80\x99s website address is www.meridianbioscience.com .\n'

Natus to Participate in the 20th Annual Needham Virtual Healthcare Conference

Retrieved on: 
Thursday, April 8, 2021
Medical diagnosis, Medical terminology, Nosology

PLEASANTON, Calif., April 08, 2021 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: NTUS) (the Company or Natus), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages, today announced that Jonathan Kennedy, President and Chief Executive Officer and Drew Davies, Executive Vice President and Chief Financial Officer will be presenting from 3:00 p.m. to 3:40 p.m. Eastern Time and hosting one-on-one meetings during the day with institutional investors at the 20th Annual Needham Virtual Healthcare Conference on Thursday, April 15th.

Key Points: 
  • PLEASANTON, Calif., April 08, 2021 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: NTUS) (the Company or Natus), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages, today announced that Jonathan Kennedy, President and Chief Executive Officer and Drew Davies, Executive Vice President and Chief Financial Officer will be presenting from 3:00 p.m. to 3:40 p.m. Eastern Time and hosting one-on-one meetings during the day with institutional investors at the 20th Annual Needham Virtual Healthcare Conference on Thursday, April 15th.
  • Investors interested in scheduling a meeting should contact a Needham representative.
  • The presentation will be webcast live and archived for 90 days on Natus Investor Relations website at https://investor.natus.com/ .
  • Natus is a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages.